Finance

Lists
AJANTPHARM:NSE
Ajanta Pharma Ltd
₹3,316.00
-0.11%
(-3.70) 1D
Nov 4, 3:30:01 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AJANTPHARM...
Open
₹3,319.70
High
₹3,336.30
Low
₹3,272.10
Mkt. cap
414.29B
Avg. vol.
134.22K
Volume
333.53K
Dividend
1.60%
Quarterly dividend
₹13.25
Ex-dividend date
Aug 5, 2026
P/E ratio
32.81
52-wk high
₹3,796.00
52-wk low
₹2,445.80
EPS
₹101.07
Shares outstanding
88.45M
No. of employees
10K
Open
₹3,319.70
High
₹3,336.30
Low
₹3,272.10
Mkt. cap
414.29B
Avg. vol.
134.22K
Volume
333.53K
Dividend
1.60%
Quarterly dividend
₹13.25
Ex-dividend date
Aug 5, 2026
P/E ratio
32.81
52-wk high
₹3,796.00
52-wk low
₹2,445.80
EPS
₹101.07
Shares outstanding
88.45M
No. of employees
10K
News stories
From web sources and news partners
Profile
Ajanta Pharma Limited is an Indian multinational pharmaceutical company. The company operates in India, the United States, and over 30 countries across Africa, Southeast Asia, West Asia, and the CIS. It was established in 1973.. Wikipedia
About Ajanta Pharma Ltd
CEO-
Employees10.4K
Founded1973
Headquarters-
SectorPharmaceutical industry
Industry-
Last report
Oct 30, 2026
Fiscal period
Q2 2027
₹31.03 / ₹26.08
+19.00%beat
Revenue / Est. (INR)
18.32B / 15.96B
+14.75%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
13.75B
14.22B
16.26B
18.32B
Cost of goods sold
2.86B
3.85B
3.28B
3.85B
Cost of revenue
2.86B
3.85B
3.28B
3.85B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.31B
3.50B
3.81B
3.84B
Operating expense
7.50B
7.05B
8.88B
9.09B
Total operating expenses
10.36B
10.90B
12.16B
12.94B
Operating income
3.39B
3.32B
4.10B
5.37B
Other non operating income
164.20M
-447.90M
204.30M
-
EBT including unusual items
3.59B
3.47B
4.47B
5.35B
EBT excluding unusual items
3.59B
4.42B
4.47B
5.35B
Income tax expense
848.30M
804.10M
1.13B
1.47B
Effective tax rate
23.66%
23.17%
25.20%
27.47%
Other operating expenses
3.76B
3.09B
4.63B
4.78B
Net income
2.74B
2.67B
3.34B
3.88B
Net profit margin
19.91%
18.76%
20.56%
21.19%
Earnings per share
21.91
21.34
26.72
31.03
Interest and investment income
-
516.00M
-
-
Interest expense
-51.00M
-23.60M
-31.80M
-22.40M
Net interest expenses
-51.00M
492.40M
-31.80M
-22.40M
Depreciation and amortization charges
435.10M
453.70M
445.00M
475.60M
EBITDA
3.70B
3.70B
4.49B
5.83B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps